Exelixis
EXEL
#1565
Rank
ยฃ8.54 B
Marketcap
ยฃ30.41
Share price
0.26%
Change (1 day)
70.71%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no stock splits for this company